jamunjar-logo
whatsapp
cartmembermenu
Search for
"test & packages"
"physiotherapy"
"heart"
"lungs"
"diabetes"
"kidney"
"liver"
"cancer"
"thyroid"
"bones"
"fever"
"vitamin"
"iron"
"HTN"

Bile pigments

Liver
image

Report in 48Hrs

image

At Home

nofastingrequire

No Fasting Required

Details

Measures bilirubin pigments.

74106

30% OFF

Bile Pigments - Comprehensive Medical Test Guide

  • Why is it done?
    • Measures breakdown products of hemoglobin metabolism, specifically bilirubin and its conjugated and unconjugated forms in blood and urine
    • Detects jaundice or icterus - yellowing of skin, sclera, and mucous membranes due to elevated bile pigment levels
    • Evaluates liver function and assesses hepatic metabolism capacity
    • Investigates biliary obstruction and cholestasis conditions affecting bile flow
    • Diagnoses hemolytic anemia and excessive red blood cell destruction
    • Ordered when patient presents with jaundice, dark urine, pale stools, or abdominal pain
    • Monitors liver disease progression or response to treatment in patients with known hepatic conditions
    • Part of routine liver function tests (LFTs) during comprehensive metabolic panels and annual physicals
  • Normal Range
    • Total Bilirubin: 0.1 to 1.2 mg/dL (1.7 to 20.5 µmol/L)
    • Direct (Conjugated) Bilirubin: 0.0 to 0.3 mg/dL (0 to 5.1 µmol/L)
    • Indirect (Unconjugated) Bilirubin: 0.1 to 0.9 mg/dL (1.7 to 15.4 µmol/L)
    • Urinary Bilirubin: Negative or trace amounts
    • Urinary Urobilinogen: 0.1 to 1.0 mg/dL or 0 to 4 mg/24 hours
    • Note: Reference ranges vary by laboratory; patient-specific results should be compared against the lab's established reference values
    • Normal results indicate appropriate hemoglobin breakdown and hepatic conjugation of bilirubin with proper excretion
    • Elevated total bilirubin above 1.2 mg/dL may cause visible jaundice, typically noticeable when levels exceed 2-3 mg/dL
  • Interpretation
    • Elevated Total Bilirubin: Indicates jaundice; pattern of elevation determines underlying cause
    • Predominantly Unconjugated Hyperbilirubinemia: Suggests hemolytic anemia, Gilbert syndrome, Crigler-Najjar syndrome, or impaired hepatic uptake; usually absent from urine
    • Predominantly Conjugated Hyperbilirubinemia: Indicates post-hepatic obstruction, cholestasis, hepatocellular injury, or excretion defects; appears in urine due to water-soluble nature
    • Elevated Urinary Bilirubin: Indicates conjugated hyperbilirubinemia exceeding renal threshold; suggests liver disease or biliary obstruction
    • Elevated Urinary Urobilinogen: Suggests increased bilirubin production from hemolysis, hepatocellular disease, or portal hypertension
    • Decreased Urinary Urobilinogen: May indicate complete biliary obstruction preventing bile pigment reaching intestines for urobilinogen formation
    • Factors Affecting Results: Hemolysis during collection, prolonged fasting, pregnancy, medications (oral contraceptives, rifampicin), diet composition, and time of day variation
    • Clinical Significance Pattern: Rapid rise in conjugated bilirubin with normal alkaline phosphatase suggests hepatocellular necrosis; elevation with elevated alkaline phosphatase indicates cholestasis
  • Associated Organs
    • Primary Organs: Liver (primary metabolic and conjugation site), biliary system (gallbladder and bile ducts), and spleen (site of hemoglobin breakdown)
    • Conditions Associated with Elevated Bile Pigments:
    • Hemolytic anemias (sickle cell disease, hereditary spherocytosis, autoimmune hemolytic anemia, G6PD deficiency)
    • Acute and chronic hepatitis (viral, autoimmune, alcoholic, drug-induced)
    • Cirrhosis and advanced liver disease from any etiology
    • Choledocholithiasis (bile duct gallstones) and biliary obstruction
    • Pancreatic cancer and cholangiocarcinoma (biliary tract cancer)
    • Primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC)
    • Pregnancy-related cholestasis and HELLP syndrome
    • Sepsis and systemic infections affecting hepatic function
    • Genetic conditions (Gilbert syndrome, Dubin-Johnson syndrome, Rotor syndrome)
    • Neonatal jaundice from physiologic hyperbilirubinemia or Rh/ABO incompatibility
    • Potential Complications: Severe unconjugated hyperbilirubinemia in neonates may cause bilirubin encephalopathy (kernicterus) with permanent neurologic damage; chronic liver disease leads to portal hypertension, ascites, variceal bleeding, and hepatic encephalopathy
  • Follow-up Tests
    • Recommended When Elevated Bile Pigments Detected:
    • Complete liver function panel: alkaline phosphatase, gamma-glutamyl transferase (GGT), aspartate aminotransferase (AST), alanine aminotransferase (ALT), albumin, total protein
    • Abdominal ultrasound to visualize biliary tree for stones, obstruction, or hepatic cirrhosis
    • Complete blood count (CBC) with reticulocyte count to assess for hemolytic anemia
    • Peripheral blood smear if hemolysis suspected to identify abnormal red blood cells
    • Haptoglobin and lactate dehydrogenase (LDH) levels for hemolysis assessment
    • Direct antiglobulin test (Coombs test) if autoimmune hemolytic anemia suspected
    • Viral hepatitis serology (hepatitis A, B, C antibodies and antigens) if hepatitis suspected
    • Autoimmune markers (ANA, anti-smooth muscle antibodies) for autoimmune hepatitis
    • CT scan or MRI/MRCP for detailed imaging of biliary tree and pancreas if obstruction suspected
    • Prothrombin time (PT/INR) to assess hepatic synthetic function if liver disease suspected
    • Endoscopic retrograde cholangiopancreatography (ERCP) if therapeutic intervention needed for biliary obstruction
    • Monitoring Frequency:
    • Acute hepatitis: repeat testing every 3-7 days until normalization
    • Chronic liver disease: repeat testing every 3-6 months or as directed by hepatologist
    • Neonatal jaundice: may require repeated testing every 24 hours in first week of life
    • Gilbert syndrome: no specific monitoring required; levels fluctuate normally with illness or stress
  • Fasting Required?
    • Fasting Status: No fasting required for bile pigment testing; test can be performed on non-fasting or fasting samples
    • Important Note: If other liver function tests or metabolic panel tests are being performed simultaneously, fasting (typically 8-12 hours) may be recommended to ensure optimal accuracy of those components
    • Special Instructions:
    • Avoid strenuous physical activity 24 hours before testing if possible, as exercise may temporarily elevate bilirubin levels
    • Avoid excessive alcohol consumption in 24 hours prior to test for accurate assessment of liver function
    • Inform healthcare provider of all current medications, especially those affecting liver function (acetaminophen, statins, NSAIDs, antibiotics, anticonvulsants)
    • Blood collection preferred in morning when diurnal variation is at baseline; avoid collection immediately after meals if possible
    • Protect specimen from light exposure as bilirubin degrades with phototherapy, affecting accuracy
    • For 24-hour urine collection (if urobilinogen assessment needed): collect all urine in 24-hour period in container without preservative unless specified by laboratory
    • Neonatal screening does not require fasting; collected via heel stick from newborn screening card

How our test process works!

customers
customers